Inotersen Subcutaneous and Insulin lispro Subcutaneous
Determining the interaction of Inotersen Subcutaneous and Insulin lispro Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotersen
Brand name: Tegsedi
Synonyms: Inotersen
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotersen Subcutaneous-Insulin NPH
- Inotersen Subcutaneous-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Inotersen Subcutaneous-Insulin NPH (Vials)
- Inotersen Subcutaneous-Insulin NPH and Insulin Regular
- Inotersen Subcutaneous-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Inotersen Subcutaneous-Insulin NPH and Insulin Regular (Vials)
- Insulin lispro Subcutaneous-Inotuzumab ozogamicin
- Insulin lispro Subcutaneous-Inotuzumab ozogamicin Intravenous
- Insulin lispro Subcutaneous-Inova
- Insulin lispro Subcutaneous-Inova 4/1 topical
- Insulin lispro Subcutaneous-Inova 8/2 topical
- Insulin lispro Subcutaneous-Inova ACT